The Food and Drug Administration's approval of Ambrientan generics and their REMS programs provide patients with additional products to treat pulmonary arterial hypertension.
The All of Us research program aims to create a large and diverse database for researchers who are developing medical breakthroughs and individualized prevention, treatment, and care.
Roughly 72% of Americans see the need for easy-to-use and effective disposal options in their homes for unused medications, according to a new survey commissioned by drug disposal company DisposeRx.
Bijuva is the only FDA-approved therapy combining bio-identical estradiol and progesterone in a single capsule to treat moderate to severe vasomotor symptoms due to menopause.